Alternatives to Atzumi If You Can't Fill Your Prescription

Atzumi (dihydroergotamine 5.2 mg nasal powder) is a brand-new migraine treatment that can be difficult to access as a newly-launched specialty drug. If you've been prescribed Atzumi and can't fill it — whether because of pharmacy availability, insurance prior authorization delays, or cost — you have real options. This guide covers the best alternatives to Atzumi and how to discuss them with your doctor.

The key question is whether you need a "same class" DHE alternative or whether you're open to a different migraine medication class entirely. We'll cover both.

Same-Drug Alternatives: Other DHE Formulations

Since Atzumi's active ingredient is dihydroergotamine (DHE), other DHE formulations offer the same mechanism of action and similar efficacy. If your prescriber specifically chose DHE over a triptan (for example, because you don't respond to triptans or have frequent migraine recurrence), these alternatives keep you in the same drug class:

Trudhesa (Dihydroergotamine Mesylate Nasal Spray)

Trudhesa is a liquid DHE nasal spray from Impel NeuroPharma that uses the Precision Olfactory Delivery (POD) device to target the upper nasal cavity for faster absorption. It was approved by the FDA in 2021. Like Atzumi, Trudhesa delivers DHE intranasally and bypasses gastrointestinal absorption. The dose is 0.725 mg per spray, one spray per nostril, for a total dose of 1.45 mg. Trudhesa is a brand-name product like Atzumi, so cash prices are also high — but it has more established formulary coverage since it's been on the market longer.

Migranal (Generic Dihydroergotamine Nasal Spray)

Generic dihydroergotamine mesylate nasal spray (the generic version of Migranal) delivers the same active ingredient as Atzumi in a liquid formulation. It's significantly less expensive than Atzumi — generic DHE nasal spray can cost around $100–$200 per vial versus $900–$1,200+ for a carton of Atzumi. The bioavailability of liquid DHE nasal spray is approximately 40%, compared to Atzumi's potentially higher and more consistent absorption due to the SMART powder technology. But for a bridge while Atzumi access is sorted out, generic DHE nasal spray is a solid option.

D.H.E. 45 (Dihydroergotamine Injection)

Injectable DHE (subcutaneous or intramuscular) offers the highest bioavailability — essentially 100% compared to intranasal delivery. It's typically used in clinical settings for refractory migraine. D.H.E. 45 (the brand IV formulation) has been discontinued but generic DHE injection is available. For self-administration, subcutaneous or IM injection is an option but less convenient than nasal delivery.

Different Class Alternatives: Triptans

Triptans are the most widely prescribed acute migraine medications. They work by stimulating the same serotonin receptors (5-HT1B/1D) as DHE, but with greater receptor selectivity and fewer cardiovascular side effects at typical doses. DHE and triptans should never be used within 24 hours of each other — but if you're switching from Atzumi to a triptan while waiting for your prescription, work with your doctor on timing.

Common triptans your doctor may recommend include:

Sumatriptan (Imitrex): The most widely prescribed triptan; available as tablet, nasal spray, and injection; generic widely available at low cost.

Rizatriptan (Maxalt): Fast-acting oral triptan; dissolving wafer form (Maxalt-MLT) is convenient; generic available.

Eletriptan (Relpax): Has higher potency and bioavailability than sumatriptan; crosses the blood-brain barrier more effectively; generic available.

Frovatriptan (Frova): Longer half-life (26 hours); particularly useful for menstrual migraines; lower recurrence rates.

Newer Alternatives: CGRP Receptor Antagonists (Gepants)

CGRP (calcitonin gene-related peptide) receptor antagonists are the newest class of acute migraine medications. Unlike DHE and triptans, gepants don't cause vasoconstriction — making them safer for patients with cardiovascular risk factors. Key gepants include:

Ubrelvy (ubrogepant): Oral tablet; effective even during the aura phase; no cardiovascular contraindications.

Nurtec ODT (rimegepant): Oral disintegrating tablet; unique dual-use: can treat acute migraine AND prevent future attacks (taken every other day).

Zavzpret (zavegepant): Nasal spray CGRP antagonist; rapid absorption; convenient for patients who prefer intranasal delivery without DHE's cardiovascular considerations.

Why Your Doctor Prescribed Atzumi Over These Alternatives

If your neurologist specifically prescribed Atzumi, they likely had a reason. DHE has a unique clinical profile that makes it valuable for certain migraine patients:

DHE is effective even when taken late in a migraine attack — long after triptans would be expected to lose effectiveness.

DHE has a lower migraine recurrence rate than most triptans.

DHE is effective for triptan non-responders.

DHE is used for medication overuse headache, status migrainosus, and menstrual migraine.

Before switching to an alternative, talk to your doctor about whether a temporary bridge or a permanent switch is more appropriate for your situation.

The Bottom Line

If you can't fill your Atzumi prescription right now, you're not without options. Other DHE formulations (Trudhesa, generic DHE nasal spray), triptans, and CGRP antagonists all offer effective migraine relief. While you're working on getting your Atzumi prescription filled, use medfinder to check pharmacy availability and ask your doctor about a bridge medication to keep you covered in the meantime.